Connect your AI

Amphastar Pharmaceuticals AMPH Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMEDCNMD

$6.23M+6.4%

Century CommunitiesCCS

$22.22M+279%

EyePoint, Inc. EYPT

$4.06M+16.7%

Essential UtilitiesWTRG

-$75K+74.4%

Equitable HoldingsEQH

$371M-5.1%

Proto LabsPRLB

$128.08M+5.2%

Segments

By segment

Pharmaceutical Products$39.26M—

Other financials

Income statement

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

Market cap$927.72M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×